原料词典检索/lecithin/LECITHIN
Tier 1 Monograph · SSOT 15 FieldsRaw .md (GEO) ↗
植物提取 (Plant)

LECITHIN

中国 NMPA《已使用化妆品原料目录 (IECIC)》标准中文名: 卵磷脂 (序号 #4456)
抗静电剂皮肤调理剂柔润剂乳化剂
[EU CosIng Official Definition] Lecithins. The complex combination of diglycerides of fatty acids linked to the choline ester of phosphoric acid
核心法规与安全结论 (Executive Fact Box)AEO / GEO CITATION ANCHOR

化妆品中 卵磷脂 (LECITHIN) 的全球法规限值与配方应用标准是什么?

卵磷脂(标准 INCI: LECITHIN,CAS 号: 8002-43-5)是化妆品配方中主要用作抗静电剂, 皮肤调理剂, 柔润剂的核心成分。受中国 NMPA(已使用/准用)、韩国 MFDS(未列管)及欧盟 CosIng(未列管)等 6 大法域法定标准监管,常规建议添加量为 0.05–5%(最佳稳定窗口 pH 4–8)。

全球 7 轨官方全成分标签名称对照表

严格采用各国政府官方目录原名 · 严禁机器翻译
7-Track Official Statutory Label Names for LECITHIN
法域与监管轨道官方公告全成分标准名称一键复制
① 韩国 (MFDS 化妆品标准名称)LECITHIN (KR MFDS Registered)
② 韩国旧名称历史 (301 重定向)——
③ 欧盟 (EU CosIng EC 1223/2009)LECITHIN
④ 美国普通化妆品 (US PCPC / MoCRA INCI)LECITHIN
⑤ 美国 OTC 防晒/祛痘专论活性物名称 (FDA OTC)— (非美国 OTC 专论活性成分 / 普通化妆品原料)—
⑥ 中国 (NMPA《已使用化妆品原料目录 IECIC》标准中文名)卵磷脂
⑦ 日本普通化妆品 / 医药部外品 (JCIA / MHLW)LECITHIN (标准 INCI 参照)

Layer 1 — 全球 6 大法域法定限值与监管状态

Layer 1 Statutory Regulatory Limits Across 6 Regions for LECITHIN
法域监管状态法定限值适用条件与法定依据来源
韩国 (MFDS)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
欧盟 (EU)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
美国 (FDA)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
中国 (NMPA)已使用/准用GMPIECIC Entry #4456
日本 (MHLW)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
东盟 (ACD)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
⚠️ 仅供参考 (免责声明): 本词典中的原料名称、法规限值与配比指南仅供研发参考。鉴于法规修订时差或潜在数据误差,实际配方设计、标签印制及备案前请务必核实主管部门最新官方公告原文;因使用本词典信息产生的任何问题,运营方概不承担法律责任。
Interactive Quartile Box-Plot (Min–Q1–Median–Q3–Max)

Layer 3 Formulation Concentration Box-Plot vs. Statutory Limit

Emulsion / Creamn=10
Min 0.05% · Q1 0.1625% · Median 0.75% · Q3 1.5% · Max 5%
Sunscreen / Colorn=25
Min 0.3% · Q1 0.8% · Median 1% · Q3 1% · Max 1.5%
Emulsion / Cream — Emulsion cream & lotion structural / conditioning agent
Verified Source: Global Starter Formulation Library Statistical Distribution (n=10, GRANT 9 · ELEMENTIS 1) (cir_safety) · GRANT 9 · ELEMENTIS 1
Typical Median: 0.75%

Layer 3 — 剂型常规配比指南与理化配伍性

Layer 3 Formulation Concentration Quartiles by Product Category for LECITHIN
剂型分类Min – Q1 – Median – Q3 – Max (%)配方作用与机理Source ID
剂型组 B — 乳液 / 面霜 (O/W · W/O)0.05% · 0.1625% · 0.75% · 1.5% · 5%Emulsion cream & lotion structural / conditioning agentGlobal Starter Formulation Library Statistical Distribution (n=10, GRANT 9 · ELEMENTIS 1)
剂型组 D — 防晒霜 / 彩妆 / 粉底0.3% · 0.8% · 1% · 1% · 1.5%Sun care & color cosmetics dispersion / sensory modifierGlobal Starter Formulation Library Statistical Distribution (n=25, GRANT 25)
Cutaneous Permeation Science (500 Dalton Rule)MW: Macro/Complex · LogP: N/A

Stratum Corneum Penetration Depth & Bio-Spicule Transdermal Delivery

Stratum Corneum (Brick & Mortar Barrier · 10–20 µm)500 Da Molecular Weight Cutoff BarrierViable Epidermis (Keratinocytes & Melanocytes · 50–100 µm)Target for Brightening (Tyrosinase/Melanosome) & Barrier LipidsPapillary Dermis (Fibroblasts & ECM Collagen · 150–300 µm)Target for Collagen I/III Synthesis, Peptides, PDRN & ExosomesEpidermal Passive Permeation (<500 Da)
Molecular Weight & LogP Permeation Diagnosis
Low Molecular Weight (320 Da ≤ 500 Da) — Passive Permeation Feasible

Under passive topical application, molecules diffuse tortuously through intercellular lipids. Hydrophilic compounds >500 Da remain primarily on the outer stratum corneum.

Estimated Target Depth
40–90 µm
Optimal Delivery System
Polyol Enhancer / Serum
Colloid Interface, pH Spectrum & Thermal Stability

pH Stability Window (0–14), Thermal Limit & HLB Colloidal Phase Behavior

Water or glycol phase soluble/dispersible
Optimal Formulation pH Stability Window (0–14)pH 4.0 – 8.0
0245.5791114

Outside pH 4–8, risk of hydrolysis, viscosity loss, or ionic dissociation increases.

Maximum Thermal Processing Limit (°C)≤ 50°C
25°C45°C60°C75°C85°C100°C

Thermally stable up to 50°C during standard emulsification.

HLB Scale (0–20) & Colloidal Micelle / Lamellar Phase Simulator
O/W Oil-in-Water Micelle Emulsion (Lotion / Cream)
HLB 11.5
W/O (3–6)Lamellar (8–10.5)O/W Emulsion (11–15)Solubilizer (15–19)O/W Droplet
Biochemical Signaling & Mechanism Pathway

Cellular & Molecular Target Mechanism Flow

1. Epidermal Interaction→ Upregulation / Activation
Intercellular Lipid & Hydration Matrix
→
TEWL Reduction & Barrier Conditioning
2. Homeostasis Modulation⊣ Inhibition / Blockade
Oxidative Stress (ROS) & Irritant Cascade
⊣
Cutaneous Soothing & Homeostasis
Formulation Ontology Radial Graph

Interactive Synergy Pairings (Solid) & Incompatibility Warnings (Dashed)

+ GLYCERIN+ CAPRYLIC/CAPRIC TR…+ TOCOPHEROL✕ Verify phase compati…LECITHIN
Interactive Node Guide

Click any green synergy node to jump directly to its monograph, or click a red dashed node to inspect the chemical incompatibility mechanism.

代表性商品名参考 (商标法第90条第1款第2项说明性标示)
LECITHIN

商品名仅供配方师识别原料规格参考,商标权归各原厂商所有。

学术与毒理综合摘要

Tier 1 Synthesis

本综述严格基于与该原料关联的 NIH PubMed 同行评审文献摘要及官方毒理学评估档案编写。

■ [1. Chemical Identity & International Labeling Nomenclature] - INCI Name: LECITHIN | CAS No.: 8002-43-5 | EC No.: 232-307-2 - Origin: PLANT | Functions: , , , - Physicochemical Profile: Formula | MW /(Polymer/Complex) | / | Ionic Nature: non-ionic | CosIng/MFDS - Official Regional Label Names: US [LECITHIN] · EU [LECITHIN] · CN [卵磷脂] · JP [-] · JP Quasi-Drug [-] ■ [2. Dermatological Mechanism of Action & Functional Role] - Lecithins. The complex combination of diglycerides of fatty acids linked to the choline ester of phosphoric acid Classified under origin 'plant', it acts within the cosmetic vehicle or stratum corneum to deliver , , , performance and structural formulation stability. ■ [3. Global 6-Jurisdiction Regulatory Status & Safety Limits (Layer 1 & Layer 2)] - Regional Summary: KR: NONE | EU: NONE | US: NONE | CN: ALLOWED | JP: NONE | ASEAN: NONE (CN IECIC (2025) Entry No. 4456 (卵磷脂)) - No specific Annex prohibition or numeric restriction across the 6 major jurisdictions (Permitted under general GMP safety assessment). - Official Safety & Historical Use Concentration (Layer 2): Quantum satis (QS) within standard cosmetic safety margins ■ [4. Formulation Dosage Guide by Product Category (Layer 3-A)] - [emulsion_cream] Typical range: 0.05 ~ 5.0% (Median 0.75%, Ref: Global Starter Formulation Library Statistical Distribution (n=10, GRANT 9 · ELEMENTIS 1)) — Emulsion cream & lotion structural / conditioning agent - [sun_color] Typical range: 0.3 ~ 1.5% (Median 1.0%, Ref: Global Starter Formulation Library Statistical Distribution (n=25, GRANT 25)) — Sun care & color cosmetics dispersion / sensory modifier ■ [5. Formulation Engineering, Stability & Incompatibility Matrix (Layer 3-B)] - Addition Phase: Water Phase or Cool-down Phase (< 45°C) - Optimal pH Range: pH 4.0 ~ 8.0 | Max Process Temp: Max 50°C | Electrolyte Tolerance: MEDIUM - Incompatibility / Caution: Verify phase compatibility under extreme pH or high electrolyte loads - Synergy Pairings: GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL | Reference Trade Names: LECITHIN ■ [6. Peer-Reviewed Literature & Official Compendia Evidence] - PMID 41987370 (2026, Skin Res Technol): Shake-Induced Temporary Ion-Pairing Between Lecithin and Glycolic Acid for Enhanced Exfoliation in a Novel Biphasic Seru - PMID 42013529 (2026, J Colloid Interface Sci): Unravelling the mechanisms behind the stabilization of oil foams using soybean lecithin - PMID 41913074 (2026, J Sci Food Agric): Recycling of hazelnut waste: Antidiabetic properties of soy lecithin nanoparticles and their in vitro anti-proliferative

关联同行评审文献 (NIH PubMed) (12)

Shake-Induced Temporary Ion-Pairing Between Lecithin and Glycolic Acid for Enhanced Exfoliation in a Novel Biphasic Serum: Comparative Ex Vivo and in Vivo Randomised Studies [PMID: 41987370 · 2026]
Kwon KC, Kim MJ · Skin Res Technol (2026)

Chemical exfoliation efficacy is significantly limited by pH-dependent permeability reduction above the pKa of glycolic acid (3.83), constraining consumer product development. To develop and evaluate a biphasic serum utilizing temporary lecithin-glycolate ion-pairing to enhance stratum corneum permeation while maintaining safety at pH 3.9. A biphasic formulation containing 10&#xa0;wt% (weight percent) glycolic acid and 0.1&#xa0;wt% lecithin was developed. Temporary ion-pairing was characterized by FT-IR spectroscopy. Ex vivo permeation and exfoliation were evaluated using porcine skin models. A 2-week double-blind, split-face clinical study (n = 37) assessed efficacy using instrumental probes (Visioscan, Corneofix, VISIA-CR, and ANTERA 3D) for exfoliation-related parameters and sensitive skin compatibility. FT-IR analysis confirmed lecithin-glycolate bonding via red-shifted C = O peaks, with spectral comparisons before and after shaking demonstrating the reversible nature of the change. The biphasic serum achieved 4.19-fold higher epidermal glycolic acid delivery compared to conventional formulations with minimal deep penetration. Clinical evaluation demonstrated superior exfoliation (45.52% improvement, p &lt; 0.001), enhanced skin brightness, texture, and hydration. Redness and transepidermal water loss, assessed for sensitive skin suitability, showed significant improvements. The biphasic system successfully overcomes pH-dependent limitations of glycolic acid through temporary ion-pairing, providing enhanced exfoliation efficacy with a superior safety profile for consumer applications.

Unravelling the mechanisms behind the stabilization of oil foams using soybean lecithin [PMID: 42013529 · 2026]
Argyri SM, Saint-Jalmes A, Ugarte-Pereyra C, Bordes R, Vincent-Bonnieu S, Le Coeur C, Binks BP, Schneck E, Fameau AL · J Colloid Interface Sci (2026)

Oil foams are emerging as a promising, versatile system in food, cosmetic and pharmaceutical applications. Existing solutions depend on the addition of particles or surfactant crystallization; however, these approaches often require complex processing steps, introduce solid residues that may affect texture, and rely on kinetically trapped interfacial structures that limit reversibility under ambient conditions. Here, we examine the foamability and stability of food-grade, soybean lecithin in oil of different surface tension. We found that edible oil foams can be formed at room temperature only in long-chain triglyceride oils. By combining microscopy, X-ray techniques, and interfacial rheology, we show that the stabilization arises from the formation of inverse lipid bilayers at the air-oil surface, leading to increased surface elastic modulus and dense thin-films that protect the gas bubbles. We also discovered that different self-assembled structures are formed in different oils. These findings uncover a molecular mechanism for non-aqueous foam stabilization under ambient conditions and establish design principles for surfactant-stabilized oil foams, without particle additives or crystallization.

Recycling of hazelnut waste: Antidiabetic properties of soy lecithin nanoparticles and their in vitro anti-proliferative effects in tumor cell lines [PMID: 41913074 · 2026]
Temiz MA, Okumus E · J Sci Food Agric (2026)

Hazelnuts and foods produced using hazelnuts are consumed with pleasure, but it is important to evaluate the waste generated during hazelnut processing and determine their usage methods. This study was conducted to determine the changes in bioactive components, bioaccessibility and antidiabetic activity of nanoparticles synthesized using soy lecithin from hazelnut wastes. The shell-derived nanoparticles had the highest zeta potential (-38.62&#x2009;mV), and the smallest particle size and polydispersity index values. The production efficiency of nanoparticles was in the range of 79.10-89.46%, and the loading capacity was in the range of 38.17-52.59%. The antioxidant properties and thermal stability of the shell nanoparticle were higher. The highest gallic acid, rutin, o-coumaric acid, quercetin and kaempferol were measured in shell nanoparticles. In the bioaccessibility results, gallic acid (69.47%), protocatechuic acid (61.28%), quercetin (61.50%) and kaempferol (52.07%) were at the highest values in the shell nanoparticle. Lipid peroxidation inhibition was highest in shell nanoparticles (8.41&#x2009;mg&#x2009;mL -1 ), while the lowest effect was measured in husk nanoparticles. The order of antidiabetic activity was shell nanoparticles &gt; skin nanoparticles &gt; husk nanoparticles. The investigation revealed that the nanoparticles exhibited significant anticancer activity in the MCF-7 breast cancer and HT-29 colon cancer cell lines. Principal component analysis showed that antioxidant properties are the key drivers of principal component one (PC1), while enzyme activities influence principal component two (PC2). The results obtained revealed the potential use of nanoparticles produced from hazelnut waste (especially shell) for therapeutic purposes and prevention of diseases associated with oxidative stress. &#xa9; 2026 The Author(s). Journal of the Science of Food and Agriculture published by John Wiley &amp; Sons Ltd on behalf of Society of Chemical Industry.

Retinol-Loaded Mannosylerythritol Lipid Nanoliposome for Enhanced Human Skin Penetration [PMID: 42246630 · 2026]
Park HW, Yoo DS, Jeong CJ, et al. · Skin Res Technol (2026)

Functional cosmetic materials with anti-aging properties, such as wrinkle reduction, often struggle to penetrate the skin's stratum corneum (skin barrier). Therefore, to exert anti-aging effects, these materials must pass through the skin barrier and reach fibroblasts in the dermal layer. In this study, deformable liposomes were developed for efficient transdermal delivery of retinol, a well-known anti-wrinkle agent. Five formulations (ML-1 to ML-5) were prepared using hydrogenated lecithin (HL) and mannosylerythritol lipid (MEL) as an edge activator with HL:MEL mass ratios of 10:0, 7:3, 5:5, 3:7, and 0:10. Their physicochemical properties, including particle size, zeta potential, polydispersity, encapsulation efficiency and deformability index were analyzed. For the optimal formulation, the liposome morphology was observed using cryo-TEM, and the retinol skin penetration ability of each liposome formulation was evaluated using a Franz diffusion cell. Their physicochemical properties were investigated, and ML-4 with an HL:MEL mass ratio of 3:7 was identified as the optimal formulation for transdermal delivery (particle size 89.3&#xb1;6.8&#xa0;nm, zeta potential -25.2&#xb1;1.1&#xa0;mV, polydispersity index 0.263&#xb1;0.012, encapsulation efficiency 86.3&#xb1;2.3%, and deformability index 5.76&#xb1;1.9). Cryo-TEM analysis confirmed the liposomal morphology of ML-4. The retinol skin penetration ability of each formulation was evaluated using the Franz diffusion cell, with the conventional liposome (ML-1) without MEL as the control. The ML-4 formulation achieved a total retinol penetration of 29.0%, a 10.6% increase compared to ML-1 (18.4%). In this study, the ML-4 deformable liposome formulation, using MEL as an edge activator, efficiently encapsulates retinol, a wrinkle improvement agent, and improves skin penetration without causing physical damage. These findings suggest that ML-4 can serve as an efficient transdermal delivery system for functional cosmetic materials.

Stratum corneum lipid remodeling as a proposed mechanism for liposomal penetration enhancement [PMID: 42242510 · 2026]
Andersen NS, Ruiz GCM, Sørensen JA, et al. · Eur J Pharm Biopharm (2026)

The stratum corneum (SC) is the principal barrier to topical and transdermal delivery, yet how lipid-based formulations interact with the SC lipid matrix remains incompletely resolved. Here, we compared conventional lecithin/cholesterol liposomes, hexosomes, ultradeformable liposomes, and a surfactant-only micelle control in ex vivo human skin after 4&#xa0;h Franz-cell exposure. Depth-resolved Laurdan generalized polarization (GP) imaging of cryosections was used to quantify formulation-induced changes in SC lipid organization, while DiD fluorescence and deuterated-lipid stimulated Raman scattering (SRS) provided orthogonal readouts of formulation-derived material within the tissue. Across formulations, GP decreased relative to matched controls, with the largest effects in the outer SC. Hexosomes produced larger outer-SC GP reductions than conventional liposomes (&#x394;GP &#x2248; 0.25-0.33 vs 0.14-0.18). In a separate donor-matched series, ultradeformable vesicles induced stronger SC remodeling than conventional liposomes, whereas Tween 20 micelles produced smaller effects. DiD and SRS signals were predominantly localized to the SC and decreased with depth, with SRS indicating a more surface-weighted distribution for rigid liposomes than for ultradeformable vesicles. Together, these findings identify formulation-dependent SC lipid remodeling, involving lipid redistribution and reduced local packing order, as a plausible mechanism by which lipid-based formulations may contribute to penetration enhancement reported in previous studies.

Impact of cationic, anionic, and amphiphilic emulsifiers on the physicochemical properties and applications of xanthan gum-shea butter bigels [PMID: 42190786 · 2026]
Jujjuri L, Elumalai S, K P V, et al. · Int J Biol Macromol (2026)

Bigels (BGs) have gained significant interest as versatile semisolid systems capable of immobilising both hydrophilic and lipophilic phases, making them suitable carriers for drug delivery. The current paper discusses the formulation of bigels (BGs) by combining xanthan gum (XG) based hydrogel (HG) with shea butter-hempseed oil-based oleogel (OG). The influence of emulsifier types, sodium dodecyl sulfate (SDS), soy lecithin (SL) and cetyltrimethylammonium bromide (CTAB), along with varying polymer concentration (1-5% w/w), on the physicochemical properties of the BGs was systematically investigated and characterized. The prepared bigels showed high oil binding capacity (&gt;95%), indicating good structural integrity. Microscopic analysis revealed that the BGs exhibited an oleogel (OG)-in-hydrogel (HG) dispersed system, corresponding to an oil-in-water (O/W) structure. Rheological studies revealed dominant elastic behaviour (G'&#xa0;&gt;&#xa0;G''), with CTAB-based formulations showing greater network strength. Fourier-transform infrared (FTIR) confirmed successful integration of hydrogel and oleogel phases without significant chemical interactions. Differential scanning calorimetry (DSC) analysis indicated improved thermal stability with increasing XG concentration, along with variations in crystallinity depending on emulsifier type. The in vitro drug release studies of Mupirocin (Mup) were best fitted by Korsmeyer-Peppas and Peppas-Sahlin models, suggesting Fickian diffusion as the principal release mechanism, with SL-based bigels showing comparatively higher drug release (~46%), Furthermore, the Mup-loaded BGs exhibited significant antimicrobial activity against Staphylococcus aureus, with inhibition zones of approximately 2.9&#xa0;cm, confirming their suitability for topical drug delivery applications.

A Kangfuxin-Loaded Lipid Gel for the Management of Radiation Dermatitis: Repair and Protection [PMID: 42173826 · 2026]
Wang T, Zhang W, Sun P, et al. · ACS Appl Mater Interfaces (2026)

Radiation therapy often causes oxidative stress and inflammation in normal tissues due to the generation of excessive radiation-induced reactive oxygen species (ROS). This can subsequently lead to radiation-induced skin injury (RISI), which manifests as tissue damage ranging from dermatitis to ulcers. One approach to addressing these challenges is to develop biocompatible functional materials that can facilitate repair and improve treatment tolerance by neutralizing ROS. In this study, a water-responsive lipid gel (LG) delivery system was constructed using Kangfuxin liquid (KFX, the ethanol extract of Periplaneta americana L.), soybean lecithin (SPC), and glycerol dioleate (GDO), based on KFX's broad-spectrum free radical scavenging ability, anti-inflammatory properties, and prorepair properties. Due to the molecular self-assembly properties of SPC and GDO, the KFX LG system can physically cross-link to form an in situ gel barrier upon contact with water. The barrier exhibits exceptional tissue adhesion, long-term slow-release properties, and good biocompatibility. The versatile KFX LG system has also been found to effectively remove various types of free radicals and reduce levels of proinflammatory factors. In a mouse model of radiation dermatitis, the radioprotective properties of the KFX lipid gel were demonstrated to be effective in alleviating radiation dermatitis. This study explored the radioprotective potential of KFX LG biomaterials in the context of radiation dermatitis, highlighting the application of radioprotectants as a promising RISI treatment strategy.

Comparison of Selected Pro-Health Biologically Active Chemical Compounds in Salviae herba from Selected Species [PMID: 42123793 · 2026]
Chwil M, Neugebauerová J, Matraszek-Gawron R, et al. · Molecules (2026)

Pharmaceutical, cosmetic, and food industries have contributed to the increasing interest in herbal phytochemicals. Salvia , a multifunctional culinary herb, meets phytotherapeutic requirements in the treatment of heartburn, excessive sweating, flatulence, and mouth, throat, and skin inflammatory conditions. Salviae folium is used in conductive education, i.e., a unique rehabilitation method for individuals with neurological and motor disorders designed to help in learning to perform activities independently. The comparative analysis of bioactive chemical compounds in S. officinalis , S. officinalis subsp. lavandulifolia , and S. sclarea herb showed that S. officinalis had the highest concentration of exogenous amino acids (53 mg&#xb7;g -1 DW), with a predominance of lecithin and phenylalanine, and endogenous amino acids were dominated by aspartic and glutamic acids. S. officinalis subsp. lavandulifolia was the richest source of omega-3, omega-6, and omega-9 fatty acids, followed by S. officinalis and S. sclarea . The vitamin C content was 4.9 ( S. sclarea )-14.4 mg&#xb7;100 g -1 DW ( S. officinalis ). Phenolic acids were dominated by rosmarinic acid ( S. officinalis &gt; S. officinalis sub. lavandulifolia &gt; S. sclarea ) and ferulic acid ( S. officinalis &gt; S. sclarea &gt; S. officinalis sub. lavandulifolia ). Salvia sclarea is a rich source of p -coumaric acid. Among non-phenolic organic acids, the highest content of quinic and malic acids was found in S. sclarea and S. officinalis , respectively. The level of o -dihydroxyphenols was 2140 ( S. officinalis )-2222 mg CAE&#xb7;100&#xb7;g -1 DW ( S. sclarea) . The flavonoid content was 610 ( S. officinalis subsp. lavandulifolia )-347 mg RU&#xb7;100 g -1 DW ( S. sclarea ). Flavonoids, flavonols, and flavanones were dominated by apigenin, kaempferol, and hesperidin, respectively. These metabolites may be potential components in phytotherapeutic products.

Assessment of skin permeation and anti-inflammatory efficacy of lornoxicam proniosomal topical gel formulations: a comparative study [PMID: 42084848 · 2026]
Alghaith AF, Mahrous GM, Shaaban DE, et al. · Pharm Dev Technol (2026)

Lornoxicam (LX) is a potent non-steroidal anti-inflammatory drug (NSAID) whose long-term oral administration is limited by gastrointestinal adverse effects. The present study aimed to develop and evaluate LX-loaded proniosomal topical gels as a strategy to enhance dermal permeation and anti-inflammatory efficacy, with direct comparison to a conventional LX gel. LX-loaded proniosomal Gels were formulated by combining lecithin, cholesterol, and a non-ionic surfactant. A conventional gel formulation was also prepared to compare its effectiveness with the proniosomal gel formulation. The vesicle size, Polydispersity index (PDI), zeta potential (ZP), encapsulation efficiency, morphology, in&#xa0;vitro LX release, ex vivo , and finally, the anti-inflammatory efficacy of both formulations was thoroughly characterized. For the proniosomal variants, vesicle sizes were recorded at 373&#x202f;&#xb1;&#x202f;29&#x202f;nm for Span 60-based proniosomes (NS) and 230&#x202f;&#xb1;&#x202f;28&#x202f;nm for Tween 80-based proniosomes (NT), with corresponding PDI values of 0.23 and 0.31 and zeta potentials of -26&#x202f;mV and -28&#x202f;mV, respectively. Encapsulation efficiency exceeded 88% across both formulations. Notably, ex vivo evaluations demonstrated markedly improved skin permeation in the proniosomal gels. The Fluxes measured 51. &#xb5;g/cm 2 /h. for NS, 18.7 relative to the standard gel (12.4). These findings were corroborated by anti-inflammatory efficacy studies, which revealed statistically significant improvements with the proniosomal gel ( p &#x2009;&lt;&#x2009;0.05) compared to the standard formulation.

Photodynamic Versus Sonodynamic Therapy In Vitro: Antimicrobial Activity of Liposomal Rose Bengal [PMID: 42083964 · 2026]
Molina-Alejandre O, Villanueva-Martínez NA, Nava-Arzaluz MG, et al. · Curr Drug Deliv (2026)

To compare the antimicrobial effect of Photodynamic (PT) and Sonodynamic Therapy (ST) applying Rose Bengal (RB) loaded in liposomes, intended for the treatment of skin infections. Formulations with standard soy lecithin (TSRB) and water-soluble soy lecithin (TWRB) were prepared and characterized by: (i) FTIR-ATR and DSC, and measuring size, polydispersity index, and zeta potential; (ii) in vitro release and permeation tests, visualizing the distribution of RB in the skin by confocal laser microscopy; (iii) stability tests under different conditions; (iv) occlusion capacity tests; (v) determination of antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa; and (vi) cytotoxicity tests with HaCaT keratinocytes. Both formulations exhibited encapsulation rates &gt; 93% and particle sizes &lt; 100 nm. TWRB was more stable, delaying RB release (12.8 % at 8h) and facilitating its penetration into the skin. MRSA was inhibited with PT and ST. P. aeruginosa was inhibited with TWRB/ST. Viability was &gt;80% in HaCaT keratinocytes treated with TWRB/PT; however, acoustic cavitation caused significant cell detachment, precluding cytotoxicity assessment in ST assays. TWRB exhibited good technological and stability properties, capable of delaying RB release while enhancing its penetration into the skin. Although MRSA (Gram-positive) was inhibited, the most interesting results were obtained with P. aeruginosa (a Gram-negative bacterium, difficult to eradicate), as TWRB/ST completely inhibited it at a lower concentration than the RB solution. The results, particularly with P. aeruginosa, provide a basis for further studies using this system.

Pregabalin-loaded transferosomal gel for enhanced topical delivery in peripheral neuropathy: formulation, in vitro and ex vivo evaluation [PMID: 42083811 · 2026]
Sanjana A M, H M A · Drug Dev Ind Pharm (2026)

To formulate and evaluate a pregabalin-loaded transferosomal gel for transdermal delivery aimed at, improving skin penetration, sustaining drug release, and increasing patient compliance in the management of peripheral neuropathy. Oral pregabalin therapy often leads to systemic side effects and variable pharmacokinetics. A transferosome-based gel offers a novel approach to improve dermal penetration, prolong drug release, and reduce systemic exposure, potentially enhancing therapeutic outcomes in neuropathic pain. Pregabalin-loaded transferosomes were prepared using the thin-film hydration method with soya lecithin and Tween 80 in varying ratios. Formulations were evaluated for particle size, polydispersity index, zeta potential, entrapment efficiency, and morphology. The optimized formulation was incorporated into a gel and assessed for pH, drug content, in vitro drug release, ex vivo permeation through goat ear skin, irritancy using the hen's egg test on the chorioallantoic membrane, and stability for 90&#x2009;days. The vesicles displayed particle sizes of 378.9-1471&#x2009;nm, a PDI of 0.3-0.8, and a zeta potential from -17.2 to -31.6&#x2009;mV. Entrapment efficiency[ee] ranged from 40.35% to 89.2%. Scanning electron microscopy confirmed smooth, spherical vesicles. The transferosomal gel showed pH 5.2-6.1 and drug content of 93.4%-98.8%. In-vitro studies demonstrated sustained 24-hour release following the Korsmeyer-Peppas model. Ex-vivo permeation showed 92.2% permeation, a flux of 467.18&#x2009;&#xb5;g/cm 2 /h, and a lag time of 0.99&#x2009;h. The gel was nonirritant and stable for 90&#x2009;days. The developed transferosomal gel exhibited sustained release, efficient permeation, and good stability, indicating strong potential as a transdermal system for peripheral neuropathy management.

Cationic Corona-Engineered Polymer-Lipid Hybrid Nanoparticles for Enhanced Dermal Penetration and Cellular Bioavailability [PMID: 41937363 · 2026]
Seo Y, Yang J, Song M, et al. · Langmuir (2026)

Cationic polymer-lipid hybrid nanoparticles were engineered to overcome cytotoxicity limitations of conventional surfactants while achieving enhanced skin penetration and controlled drug release. Poly(2-ethyl-2-oxazoline)- block -poly(&#x3b5;-caprolactone) (POx- b -PCL) copolymers were synthesized via ring-opening polymerization and coassembled with lecithin through nanoprecipitation, yielding spherical nanoparticles (&#x223c;120 nm). Differential scanning calorimetry and NMR relaxometry confirmed that POx- b -PCL incorporation progressively increased the crystallinity and rigidity of the nanoparticle core, achieving 2-fold reduction in Higuchi release rate constants for sustained curcumin delivery. Biolayer interferometry demonstrated 10-fold enhanced binding affinity toward negatively charged albumin through multivalent electrostatic interactions, correlating with substantially improved cellular internalization in HaCaT keratinocytes. Confocal microscopy of ex vivo porcine skin revealed 70% increased transdermal penetration depth, with maximum fluorescence at 30-40 &#x3bc;m beneath the stratum corneum. These biocompatible nanocarriers synergistically integrate controlled release kinetics with cationic surface chemistry, presenting a promising platform for transdermal drug delivery and topical therapeutic applications.

常见问题解答 (FAQ)

Q1. 卵磷脂 (LECITHIN) 在全球 7 大法域的官方全成分标签名称是什么?
中国 NMPA《已使用化妆品原料目录 (IECIC)》标准中文名为 '卵磷脂',美国 PCPC 与欧盟 CosIng 标准 INCI 为 'LECITHIN',日本 JCIA 表示名称为 'LECITHIN'。
Q2. 卵磷脂 (LECITHIN) 在中、韩、欧、美、日、东盟的法定监管状态 (Layer 1) 如何?
6 大法域监管汇总 — 中国(CN): allowed,韩国(KR): none,欧盟(EU): none,美国(US): none,日本(JP): none,东盟(ASEAN): none。
Q3. 卵磷脂 (LECITHIN) 的常规配方添加量 (Layer 3) 与最佳稳定 pH 窗口是多少?
在代表性剂型 (emulsion_cream) 中常规添加量为 0.05%–5%(中位数 0.75%),最佳稳定 pH 范围为 4–8。
Q4. 卵磷脂 (LECITHIN) 有哪些配伍禁忌 (Incompatibilities) 与协同增效组合?
推荐协同组合包括 GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL;配伍禁忌注意:Verify phase compatibility under extreme pH or high electrolyte loads。